Ventavis Related Published Studies
Well-designed clinical trials related to Ventavis (Iloprost Inhalation)
Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension. [2008.09.10]
A randomized trial of iloprost in patients with intermittent claudication. [2008.02]
Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. [2008.01]
Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. [2007.11.01]
The treatment of venous leg ulcers: a new therapeutic use of iloprost. [2007.11]
An alternative agent for radial arterial graft spasm: application of topical iloprost. [2007.06]
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. [2006.12.01]
A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery. [2006.10]
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension. [2006.10]
The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery. [2006.08]
Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study. [2006.08]
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. [2006.08]
A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease. [2006.06]
Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. [2005.12]
Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study. [2005.04]
Well-designed clinical trials possibly related to Ventavis (Iloprost Inhalation)
Evidence-based pharmacologic management of pulmonary arterial hypertension. [2007.10]
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. [2006.12]
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. [2006.10.17]
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. [2006.04]
[Emerging Therapies for the Treatment of Pulmonary Arterial Hypertension.] [2005.06]
Other research related to Ventavis (Iloprost Inhalation)
Iloprost Downregulates Expression of Adhesion Molecules and Reduces Renal Injury Induced by Abdominal Aortic Ischemia-Reperfusion. [2008.09.05]
Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study. [2008.09]
Low versus High-dose Iloprost Therapy Over 21 Days in Patients with Secondary Raynaud's Phenomenon and Systemic Sclerosis: A Randomized, Open, Single-center Study. [2008.07.15]
MRI-demonstrated outcome of subchondral stress fractures of the knee after treatment with iloprost or tramadol: observations in 14 patients. [2008.07]
Effects of inhaled aerosolized iloprost and inhaled NO on pulmonary circulation and edema formation in ovine lung injury. [2008.07]
Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model. [2008.06.01]
Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. [2008.06]
[Iloprost for the treatment of systemic sclerosis] [2008.05]
The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study. [2008.04]
Iloprost pretreatment before unilateral nephrectomy: an experimental study in rats. [2008.04]
Protection of the Spinal Cord from Ischemia: Comparative Effects of Levosimendan and Iloprost. [2008.03.20]
[Inhalatives Iloprost in der Therapie des pulmonalen Hypertonus bei sehr kleinen Fruhgeborenen: Eine Pilotstudie.] [2008.03]
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. [2008.03]
Iloprost infusion does not reduce oxidative stress in systemic sclerosis. [2008.02]
Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. [2008.01.15]
Role of iloprost and bosentan in pulmonary arterial hypertension. [2008.01]
Protection of the spinal cord from ischemia: comparative effects of levosimendan and iloprost. [2008]
Inhaled iloprost for hepatopulmonary syndrome: improvement of hypoxemia. [2007.12]
Experience with inhaled iloprost and bosentan in portopulmonary hypertension. [2007.12]
Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography. [2007.11.21]
Aerosolized iloprost customized for the critically ill. [2007.11]
Hypoxia-induced pulmonary hypertension: different impact of iloprost, sildenafil, and nitric oxide. [2007.10]
Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment. [2007.09]
Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients. [2007.09]
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis. [2007.09]
Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis. [2007.09]
Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group. [2007.09]
[Inhalatives Iloprost in der Therapie des pulmonalen Hypertonus bei sehr kleinen Fruhgeborenen: Eine Pilotstudie.] [2007.08.21]
Influence of the stable protacyclin analog iloprost on the healing of colonic anastomosis in rats. [2007.08]
Acute Limb Ischemia in Elderly Patients: Can Iloprost be Useful as an Adjuvant to Surgery? Results from the ILAILL Study. [2007.08]
Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients. [2007.07.17]
Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. [2007.06]
Effect of iloprost on impaired anastomotic healing caused by 5-fluorouracil plus leucovorin. [2007.06]
Preischemic iloprost application for improvement of graft preservation: which route is superior in experimental pig lung transplantation: inhaled or intravenous? [2007.06]
Iloprost-induced sudden hearing loss. [2007.06]
Short-term intravenous iloprost for treatment of reperfusion lung oedema after pulmonary thromboendarterectomy. [2007.05]
Acute Limb Ischemia in Elderly Patients: Can Iloprost be Useful as an Adjuvant to Surgery? Results from the ILAILL Study. [2007.04.10]
Use of microsurgery and iloprost in the infantile arterial injuries. [2007.04]
Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. [2007.04]
Effect of Iloprost on Impaired Anastomotic Healing Caused by 5-Fluorouracil plus Leucovorin. [2007.03.12]
Intravenous iloprost: a new therapeutic option for patients with post-transplant distal limb syndrome (PTDLS). [2007.03]
Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. [2007.02]
Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study. [2007.02]
Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability. [2007.02]
Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension. [2007.02]
Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. [2007.01.31]
Inhaled iloprost for severe persistent pulmonary hypertension of the newborn. [2007.01]
Cocaine-related peripheral vascular occlusive disease treated with iloprost in addition to anticoagulants and antibiotics. [2007]
Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. [2007]
Effect of inhaled iloprost during off-medication time in patients with pulmonary arterial hypertension. [2007]
The effect of inhaled nitric oxide and inhaled iloprost on hypoxaemia in a patient with pulmonary hypertension after pulmonary thrombarterectomy. [2006.12]
Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction. [2006.11]
PEG-hirudin/iloprost coating of small diameter ePTFE grafts effectively prevents pseudointima and intimal hyperplasia development. [2006.10]
Comparison of pharmacokinetics and vasodilatory effect of nebulized and infused iloprost in experimental pulmonary hypertension: rapid tolerance development. [2006.09]
Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease. [2006.09]
Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia. [2006.08]
Be aware of bone marrow edema syndrome in ankle arthroscopy: a case successfully treated with iloprost. [2006.08]
Effects of Iloprost and pentoxifylline on renal ischemia-reperfusion in rabbit model. [2006.07.31]
Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis. [2006.06]
Effects of iloprost on visual evoked potentials and brain tissue oxidative stress after bilateral common carotid artery occlusion. [2006.06]
Acute resynchronization with inhaled iloprost in a pregnant woman with idiopathic pulmonary artery hypertension. [2006.05]
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis. [2006.05]
Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression. [2006.05]
The combined effect of iloprost and N-acetylcysteine in preventing spinal cord ischemia in rabbits. [2006.04]
Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases. [2006.03]
Recurrent arterial thromboses in a woman with heparin induced thrombocytopenia, successfully managed with iloprost followed by clopidogrel. An alternative therapeutic option for heparin induced thrombocytopenia type II syndrome. [2006.03]
Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension. [2006.02]
Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results. [2006.02]
Evaluation of finger skin temperature in scleroderma patients cyclically treated with iloprost. [2006.01]
Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost. [2006.01]
Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension. [2006]
Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery. [2006]
Iloprost infusion in diabetic patients with peripheral arterial occlusive disease and foot ulcers. [2005.11]
Use of long-term combined therapy with inhaled iloprost and oral sildenafil in an adult patient with eisenmenger syndrome. [2005.11]
Iloprost treatment reduces TNF-alpha production and TNF-RII expression in critical limb ischemia patients without affecting IL6. [2005.11]
Inhalative pre-treatment of donor lungs using the aerosolized prostacyclin analog iloprost ameliorates reperfusion injury. [2005.10]
Iloprost in embolic renal failure. [2005.09]
Iloprost inhalation solution for the treatment of pulmonary arterial hypertension. [2005.09]
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. [2005.09]
Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension. [2005.08.01]
Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan. [2005.08]
|
